BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3390960)

  • 1. Plasma levels and renal clearance of two isomers of dopamine sulfate in patients with essential hypertension.
    Hashizume K; Ogihara T; Yamatodani A; Yamamoto T; Wada H; Kumahara Y
    Clin Exp Hypertens A; 1988; 10(4):561-74. PubMed ID: 3390960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catecholamines in plasma and urine in patients with essential hypertension determined by double-isotope derivative techniques.
    Pedersen EB; Christensen NJ
    Acta Med Scand; 1975 Nov; 198(5):373-7. PubMed ID: 1199813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma and urinary catecholamines and metabolites during physical exercise in essential hypertension.
    Chodakowska J; Wocial B; Skórka B; Nazar K; Chwalbińska-Moneta J
    Acta Physiol Pol; 1980; 31(6):623-30. PubMed ID: 6787836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenomedullary secretion of epinephrine is increased in mild essential hypertension.
    Jacobs MC; Lenders JW; Willemsen JJ; Thien T
    Hypertension; 1997 Jun; 29(6):1303-8. PubMed ID: 9180633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased urinary dopamine excretion in young patients with essential hypertension.
    Saito I; Itsuji S; Takeshita E; Kawabe H; Nishino M; Wainai H; Hasegawa C; Saruta T; Nagano S; Sekihara T
    Clin Exp Hypertens; 1994 Jan; 16(1):29-39. PubMed ID: 8136773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased plasma adrenaline concentrations in benign essential hypertension.
    Franco-Morselli R; Elghozi JL; Joly E; Di Giuilio S; Meyer P
    Br Med J; 1977 Nov; 2(6097):1251-4. PubMed ID: 589124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma catecholamines and essential hypertension. An analytical review.
    Goldstein DS
    Hypertension; 1983; 5(1):86-99. PubMed ID: 6336721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine calcium excretion, nephrogenous cyclic-adenosine monophosphate and serum parathyroid hormone levels in patients with essential hypertension.
    Papagalanis ND; Skopelitis P; Kourti A; Kostogianni G; Karabatsos A; Gennadiou M; Thomas S; Samartzis M; Mountokalakis T
    Nephron; 1991; 59(2):226-31. PubMed ID: 1659670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noradrenaline clearance in hypertensive patients with various degrees of renal function.
    Masuyama Y; Nishimura T; Nishio I; Kuchii M
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():213s-215s. PubMed ID: 540434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociation of 24-hour catecholamine levels from blood pressure in older men.
    Stern N; Beahm E; McGinty D; Eggena P; Littner M; Nyby M; Catania R; Sowers JR
    Hypertension; 1985; 7(6 Pt 1):1023-9. PubMed ID: 4077217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of the renal dopaminergic and the prostaglandin systems in renal uric acid metabolism in patients with essential hypertension].
    Satoh N; Kikuchi K; Hasegawa T; Komura H; Suzuki S; Ohtomo T; Takada T; Nanba M; Marusaki S; Iimura O
    Nihon Naibunpi Gakkai Zasshi; 1991 Nov; 67(11):1271-81. PubMed ID: 1761141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of oral and intravenous administrations of dopamine and L-dopa on plasma levels of two isomers of dopamine sulfate in man.
    Hashizume K; Yamatodani A; Yamamoto T; Ogihara T; Kumahara Y; Wada H
    Life Sci; 1987 Dec; 41(25):2697-704. PubMed ID: 3695802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased central dopaminergic activity in essential hypertension.
    Os I; Kjeldsen SE; Westheim A; Aakesson I; Norman N; Enger E; Hjermann I; Eide I
    J Hypertens; 1987 Apr; 5(2):191-7. PubMed ID: 3611768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective dopamine generation from dihydroxyphenylalanine in stable essential hypertensive patients.
    Kuchel O; Shigetomi S
    Hypertension; 1992 Jun; 19(6 Pt 2):634-8. PubMed ID: 1592460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of graded low-dose noradrenaline infusions on noradrenaline clearance in normals and essential hypertensives.
    Gordon RD; Bachmann AW; Gueizelar B; Dai Y
    Clin Exp Pharmacol Physiol; 1987 Mar; 14(3):163-7. PubMed ID: 3665191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of aging on the insulin actions for the glucose metabolism and renal function in normotensives and essential hypertensives.
    Miyazaki Y; Hirata A; Murakami H; Fukuoka M; Agata J; Higashiura K; Masuda A; Ura N; Shimamoto K
    Am J Hypertens; 1998 Sep; 11(9):1056-64. PubMed ID: 9752890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability in the relationship between serum creatinine and creatinine clearance in hypertensives and normotensives with normal renal function.
    Kadiri S; Ajayi SO
    Afr J Med Med Sci; 2000 Jun; 29(2):93-6. PubMed ID: 11379457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of nisoldipine on stress-induced changes in haemodynamics and plasma catecholamines in normotensives and hypertensives.
    Ludwig J; Gerhardt T; Halbrügge T; Walter J; Heidbreder E; Graefe KH
    J Hum Hypertens; 1990 Dec; 4(6):693-701. PubMed ID: 2096212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Plasma norepinephrine variation with dietary sodium intake in normotensive subjects and patients with essential hypertension].
    Masuo K; Ogihara T; Kumahara Y; Yamatodani A; Wada H
    Nihon Naibunpi Gakkai Zasshi; 1982 Sep; 58(9):1055-66. PubMed ID: 7173454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased platelet-free dopamine and unchanged noradrenaline and adrenaline in essential hypertension.
    Kjeldsen SE; Gjesdal K; Leren P; Eide IK
    Thromb Haemost; 1988 Oct; 60(2):251-4. PubMed ID: 3217920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.